Summit Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | 08/14/2026 | 32.79 M | $477.70 M | -9.91% | 4.21% |
| FMR LLC | 08/13/2026 | 10.04 M | $146.34 M | -7.46% | 1.29% |
| STATE STREET CORP | 08/07/2026 | 9.54 M | $138.95 M | 35.69% | 1.23% |
| BLACKROCK, INC. | 08/07/2026 | 9.53 M | $138.84 M | -1.29% | 1.22% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 5.73 M | $83.55 M | 0.40% | 0.74% |
| UBS GROUP AG | 08/13/2026 | 5.23 M | $76.26 M | 42.21% | 0.67% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 08/13/2026 | 5.04 M | $73.46 M | -3.65% | 0.65% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 4.51 M | $65.76 M | 1,352.52% | 0.58% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 08/14/2026 | 3.89 M | $56.73 M | -52.96% | 0.50% |
| POINT72 ASSET MANAGEMENT, L.P. | 08/14/2026 | 3.70 M | $53.88 M | 371.55% | 0.48% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 3.43 M | $49.95 M | 3.36% | 0.44% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2026 | 2.35 M | $34.23 M | 1,760.32% | 0.30% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 08/14/2026 | 1.99 M | $28.99 M | 100.00% | 0.26% |
| BALYASNY ASSET MANAGEMENT L.P. | 08/14/2026 | 1.90 M | $27.74 M | 247.28% | 0.24% |
| CITADEL ADVISORS LLC | 09/02/2026 | 1.73 M | $25.14 M | 290.66% | 0.22% |
| ABRDN PLC | 07/31/2026 | 1.69 M | $24.68 M | 154.54% | 0.22% |
| SQUAREPOINT OPS LLC | 08/14/2026 | 1.59 M | $23.18 M | 159.13% | 0.20% |
| MORGAN STANLEY | 08/13/2026 | 1.45 M | $21.13 M | -12.15% | 0.19% |
| NORGES BANK | 08/12/2026 | 1.38 M | $20.14 M | 100.00% | 0.18% |
| LOGOS GLOBAL MANAGEMENT LP | 08/14/2026 | 1.35 M | $19.67 M | 100.00% | 0.17% |
| OCTAGON CAPITAL ADVISORS LP | 08/14/2026 | 1.25 M | $18.21 M | 100.00% | 0.16% |
| D. E. SHAW & CO., INC. | 08/14/2026 | 1.24 M | $18.12 M | -44.54% | 0.16% |
| KYNAM CAPITAL MANAGEMENT, LP | 08/14/2026 | 1.20 M | $17.48 M | 100.00% | 0.15% |
| PICTET ASSET MANAGEMENT HOLDING SA | 07/30/2026 | 1.13 M | $16.43 M | -14.27% | 0.15% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 1.11 M | $16.16 M | -10.50% | 0.14% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/14/2026 | 976.85 K | $14.23 M | 1.66% | 0.13% |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 08/14/2026 | 976.85 K | $14.23 M | 100.00% | 0.13% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 966.59 K | $14.08 M | 3.45% | 0.12% |
| APEIRON CAPITAL LTD | 08/06/2026 | 961.87 K | $14.01 M | -26.53% | 0.12% |
| BANK OF AMERICA CORP /DE/ | 08/14/2026 | 864.98 K | $12.60 M | 44.48% | 0.11% |
| DIADEMA PARTNERS LP | 08/14/2026 | 860.20 K | $12.53 M | 100.00% | 0.11% |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 08/13/2026 | 835.96 K | $11.97 M | 232.54% | 0.11% |
| LMR PARTNERS LLP | 08/14/2026 | 820.40 K | $11.95 M | 36.64% | 0.11% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 770.50 K | $11.23 M | 35.77% | 0.10% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 08/14/2026 | 715.00 K | $10.42 M | 0.70% | 0.09% |
| CITIGROUP INC | 08/03/2026 | 714.00 K | $10.40 M | 258.55% | 0.09% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2026 | 696.71 K | $10.15 M | -28.99% | 0.09% |
| CITADEL ADVISORS LLC | 09/02/2026 | 641.90 K | $9.35 M | 26.96% | 0.08% |
| NORTHERN TRUST CORP | 08/13/2026 | 633.79 K | $9.23 M | 8.97% | 0.08% |
| MARSHALL WACE, LLP | 08/13/2026 | 577.19 K | $8.41 M | 21.45% | 0.07% |
| AQR CAPITAL MANAGEMENT LLC | 08/14/2026 | 542.18 K | $7.90 M | 22.18% | 0.07% |
| CANDRIAM S.C.A. | 08/13/2026 | 532.43 K | $7.75 M | -1.52% | 0.07% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 521.34 K | $7.60 M | -13.68% | 0.07% |
| CITADEL ADVISORS LLC | 09/02/2026 | 507.50 K | $7.39 M | 346.74% | 0.07% |
| ELMIND CAPITAL, LP | 08/14/2026 | 493.82 K | $7.19 M | 100.00% | 0.06% |
| WELLINGTON MANAGEMENT GROUP LLP | 08/14/2026 | 441.93 K | $6.44 M | 21.79% | 0.06% |
| BANK OF NEW YORK MELLON CORP | 08/06/2026 | 431.30 K | $6.28 M | 6.58% | 0.06% |
| WORLDQUANT MILLENNIUM ADVISORS LLC | 08/14/2026 | 431.03 K | $6.28 M | 639.68% | 0.06% |
| TD ASSET MANAGEMENT INC | 08/04/2026 | 426.08 K | $6.21 M | -55.47% | 0.05% |
| INVESCO LTD. | 08/14/2026 | 416.85 K | $6.07 M | -20.77% | 0.05% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Summit Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 308 institutional investors and hedge funds held shares of Summit Therapeutics Inc. The most heavily invested institutionals were:
BAKER BROS. ADVISORS LP: 32.79 M
FMR LLC: 10.04 M
STATE STREET CORP: 9.54 M
BlackRock, Inc.: 9.53 M
VANGUARD CAPITAL MANAGEMENT LLC: 5.73 M
UBS Group AG: 5.23 M
17.59% of Summit Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 162.34 M shares in the last 24 months. This purchase volume represents approximately $2.55 B in transactions.